Evidence map›Paper›PMID 23971914›Full record

ArticleViral immunology2013

In vivo modulation of avidity in highly sensitive CD8(+) effector T cells following viral infection.

Beth C Holbrook, Rama D Yammani, Lance K Blevins, Martha A Alexander-Miller

Abstract read
In one paragraph

Article in Viral immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Beth C HolbrookDepartment of Microbiology and Immunology, Wake Forest University School of Medicine , Winston-Salem, North Carolina.
Rama D Yammani
Lance K Blevins
Martha A Alexander-Miller

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Cellular Immune Response to Respiratory InfectionR01HL071985 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALEXANDER-MILLER, MARTHA ANN · 2004 to 2010
$2.4M
Control of cytotoxic T cell differentiation and activityR01AI043591 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALEXANDER-MILLER, MARTHA ANN · 1999 to 2009
$2.2M
NCI NIH HHS P30 CA012197NHLBI NIH HHS R01 HL071985NIAID NIH HHS R01 AI043591
6 · The paper itself

Abstract

Numerous studies have demonstrated a critical role for T cell avidity in predicting in vivo efficacy. Even though the measurement of avidity is now a routine assessment for the analysis of effector and memory T cell populations, our understanding of how this property is controlled in vivo at both the population and individual cell levels is limited. Our previous studies have identified high avidity as a property of the initial effector population generated in mice following respiratory virus infection. As the response progresses, lower avidity cells appear in the effector pool. The studies described here investigate the mechanistic basis of this in vivo regulation of avidity. We present data supporting in vivo avidity modulation within the early high avidity responders that results in a population of lower avidity effector cells. Changes in avidity were correlated with decreased lck expression and increased sensitivity to lck inhibitors in effector cells present at late versus early times postinfection. The possibility of tuning within select individual effectors is a previously unappreciated mechanism for the control of avidity in vivo.

Indexed as

Adoptive TransferAnimalsAntigens, ViralFemaleInterleukin-2 Receptor alpha SubunitLymphocyte ActivationLymphocyte Specific Protein Tyrosine Kinase p56(lck)MiceMice, Inbred BALB CParainfluenza Virus 5Protein BindingRubulavirus InfectionsT-Lymphocytes, CytotoxicAntigens, ViralInterleukin-2 Receptor alpha SubunitLymphocyte Specific Protein Tyrosine Kinase p56(lck)

Identifiers

PMID23971914
PMCPMC3797458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.